Borsantrazole extended survival in a mouse model of ALS
Original source
Introducing Borsantrazole: A Trifunctional Boron-Based Pyrazole That Extends the Lifespan of Amyotrophic Lateral Sclerosis Mice. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Mouse
Population inferred from the title and abstract by Compass.
Related topics
Borsantrazole increased survival, delayed disease and symptom onset, and reduced weight loss in SOD1-G37R mice, according to a primary research study. The compound also changed proteins and phosphorylation sites linked to cellular processes. These results are preclinical and do not show that borsantrazole is safe or effective in people with ALS.
Why this matters
The findings may support further development of borsantrazole as a possible ALS treatment. However, they currently affect research rather than patient care because the reported testing was in mice and cells, not people.
Limitations and context
The study tested borsantrazole in cell-based experiments and in an SOD1-G37R mouse model, along with toxicity models. The source does not provide human clinical results, so its safety and effectiveness in people remain unknown. The study reports potential for further clinical development, not an established treatment benefit.